Bioventures Opportunities G. Yk Sells 2,998,908 Shares of CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) Stock

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) major shareholder Bioventures Opportunities G. Yk sold 2,998,908 shares of the firm’s stock in a transaction that occurred on Friday, December 13th. The stock was sold at an average price of $0.06, for a total transaction of $179,934.48. Following the transaction, the insider now directly owns 13,005,169 shares in the company, valued at approximately $780,310.14. This trade represents a 18.74 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

CERo Therapeutics Stock Down 18.5 %

NASDAQ:CERO opened at $0.06 on Friday. CERo Therapeutics Holdings, Inc. has a 1-year low of $0.06 and a 1-year high of $12.80. The company has a 50-day moving average of $0.13 and a 200 day moving average of $0.22.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.